Digital Therapeutics: Beyond Coding to Coverage and Evidence Frameworks

HealthLeaders Media September 12, 2022
Laura Beerman

“Particularly for payers now, you need to show economic outcomes and savings,” says one company founder.

KEY TAKEAWAYS

– Healthcare innovations face a frequent challenge: how to disrupt while riding the rails of deeply entrenched infrastructure.

– Digital therapeutics are one example of a market still in search of ways to cover and bill its products.

– Coding strides in 2022 pushed progress but fell short of the overarching coverage categories needed for payer uptake.

Until fairly recently, digital therapeutics (DTx) simply weren’t on healthcare’s shelf.

These products “deliver medical interventions directly to patients using evidence-based, clinically evaluated software to treat, manage, and prevent a broad spectrum of diseases and disorders” alongside medication. Examples include mental health applications from BehaVR...

Today's Sponsors

Today's Sponsor